Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PIAM Farmaceutici is a long-standing Italian pharmaceutical company based in Genoa, specializing in niche therapeutic areas and rare diseases. Founded in 1915, the company has established a leadership position in the treatment of inherited metabolic disorders, particularly Phenylketonuria (PKU), through its extensive line of medical foods and specialized supplements. Beyond orphan drugs, PIAM operates significantly in the cardiovascular, neurological, and respiratory sectors, offering a portfolio of ethical drugs and nutraceuticals. The company follows a business model that combines internal R&D with strategic licensing agreements to bring specialized treatments to the Italian and international markets. PIAM is recognized for its commitment to high-quality standards and its focus on improving the quality of life for patients with chronic and rare conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PIAM Farmaceutici.